Published in Cell Mol Neurobiol on December 01, 2004
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One (2010) 2.08
Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference. Prion (2011) 0.91
Brain transcriptional stability upon prion protein-encoding gene invalidation in zygotic or adult mouse. BMC Genomics (2010) 0.84
Roles of Circular RNAs in Neurologic Disease. Front Mol Neurosci (2016) 0.81
The CAG repeat in SCA12 functions as a cis element to up-regulate PPP2R2B expression. Hum Genet (2010) 0.80
Prion protein function and the disturbance of early embryonic development in zebrafish. Prion (2011) 0.79
Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells. Prion (2010) 0.77
Efficient PRNP deletion in bovine genome using gene-editing technologies in bovine cells. Prion (2015) 0.75
Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer. World J Gastroenterol (2017) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Activation of the interferon system by short-interfering RNAs. Nat Cell Biol (2003) 8.63
Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem (1998) 6.26
Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell (1996) 5.27
Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science (1999) 4.69
Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci (1999) 4.42
Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell (1994) 3.95
The cellular prion protein binds copper in vivo. Nature (1998) 3.92
129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol (1995) 3.60
Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science (2002) 3.05
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol (1999) 2.92
Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A (1996) 2.79
Prion protein is necessary for normal synaptic function. Nature (1994) 2.69
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell (1994) 2.68
Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem (1995) 2.62
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature (1996) 2.24
Prions prevent neuronal cell-line death. Nature (1999) 2.13
Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature (1996) 2.13
Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J (2001) 2.10
Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology (1992) 2.00
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med (2001) 1.99
Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A (1990) 1.87
Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem J (2001) 1.85
Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J (2001) 1.85
Selective neuronal targeting in prion disease. Neuron (1997) 1.82
Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat Genet (1999) 1.74
Protein factor requirements of the Apaf-1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras. Mol Cell Biol (2001) 1.73
Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol (2001) 1.63
Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem (1999) 1.54
Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression. Neuron (1999) 1.52
Doppel-induced cerebellar degeneration in transgenic mice. Proc Natl Acad Sci U S A (2001) 1.52
Cellular prion protein transduces neuroprotective signals. EMBO J (2002) 1.47
Cytosolic prion protein in neurons. J Neurosci (2003) 1.34
Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res (2000) 1.34
Atypical inflammation in the central nervous system in prion disease. Curr Opin Neurol (2002) 1.32
Molecular cloning and mapping of human semaphorin F from the Cri-du-chat candidate interval. Biochem Biophys Res Commun (1998) 1.21
SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol (2001) 1.20
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proc Natl Acad Sci U S A (1990) 1.19
Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem (2002) 1.15
Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol (2002) 1.14
Signaling cascade regulating long-term potentiation of GABA(A) receptor responsiveness in cerebellar Purkinje neurons. J Neurosci (2002) 1.06
HSP22, a new member of the small heat shock protein superfamily, interacts with mimic of phosphorylated HSP27 ((3D)HSP27). J Biol Chem (2001) 1.02
Assembly and enzymatic properties of the catalytic domain of human complement protease C1r. J Biol Chem (2001) 0.99
A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology (2002) 0.99
Overexpression of PrPc triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti-PrP antibodies. J Neurochem (2002) 0.98
Regulated interaction of endothelin B receptor with caveolin-1. Eur J Biochem (2003) 0.98
Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur J Neurosci (2002) 0.96
Prion protein affects Ca2+-activated K+ currents in cerebellar purkinje cells. Neurobiol Dis (2001) 0.95
Differential gene expression between human neurons and neuronal progenitor cells in culture: an analysis of arrayed cDNA clones in NTera2 human embryonal carcinoma cell line as a model system. J Neurosci Methods (2000) 0.93
Cellular prion protein is expressed in the human enteric nervous system. Nat Med (2000) 0.86
GBAS, a novel gene encoding a protein with tyrosine phosphorylation sites and a transmembrane domain, is co-amplified with EGFR. Genomics (1998) 0.86
Gene expression profile in prion protein-deficient fibroblasts in culture. Am J Pathol (2000) 0.84
Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis. J Neuroimmunol (2003) 0.82
Prion and doppel proteins bind to granule cells of the cerebellum. Proc Natl Acad Sci U S A (2002) 0.82
Prion proteins meet protein quality control. Trends Cell Biol (2003) 0.81
Cultured skin fibroblasts isolated from mice devoid of the prion protein gene express major heat shock proteins in response to heat stress. Exp Neurol (1998) 0.78
Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency. Hum Mutat (2003) 0.77
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med (2002) 4.34
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci U S A (2005) 2.83
Thyrotrophin in the pars tuberalis triggers photoperiodic response. Nature (2008) 2.60
The regulatory role of natural killer cells in multiple sclerosis. Brain (2004) 1.84
Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J Immunol (2007) 1.77
Circadian clock gene regulation of steroidogenic acute regulatory protein gene expression in preovulatory ovarian follicles. Endocrinology (2007) 1.74
Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum (2004) 1.74
Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol (2006) 1.72
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med (2007) 1.69
Light-induced hormone conversion of T4 to T3 regulates photoperiodic response of gonads in birds. Nature (2003) 1.67
Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J Immunol (2007) 1.67
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology (2014) 1.62
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest (2004) 1.61
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest (2010) 1.60
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci U S A (2011) 1.60
Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int (2008) 1.54
A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol (2004) 1.46
Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol (2005) 1.45
Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategies. Immunotherapy (2009) 1.39
Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected]. J Immunol (2003) 1.38
NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol (2008) 1.35
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol (2011) 1.33
Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. JAMA Neurol (2013) 1.30
Natural killer T cells accelerate atherogenesis in mice. Blood (2004) 1.28
CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol (2003) 1.25
Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol (2003) 1.21
Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis (2005) 1.20
Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol (2004) 1.20
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Mod Rheumatol (2012) 1.17
Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol (2007) 1.16
Human astrocytes express aquaporin-1 and aquaporin-4 in vitro and in vivo. Neuropathology (2007) 1.14
T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J Neuroimmunol (2006) 1.13
IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood (2005) 1.12
NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J Immunol (2005) 1.09
Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rheum (2012) 1.08
Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol (2003) 1.08
Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J Immunol (2005) 1.06
Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am J Pathol (2009) 1.05
Photoperiodic regulation of type 2 deiodinase gene in Djungarian hamster: possible homologies between avian and mammalian photoperiodic regulation of reproduction. Endocrinology (2004) 1.05
Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc Natl Acad Sci U S A (2008) 1.04
Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int Immunol (2005) 1.04
Hypothalamic expression of thyroid hormone-activating and -inactivating enzyme genes in relation to photorefractoriness in birds and mammals. Am J Physiol Regul Integr Comp Physiol (2007) 1.03
Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol (2005) 1.03
Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis (2005) 1.02
Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J Autoimmun (2004) 1.02
The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models. Arthritis Rheum (2005) 1.01
Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway. Brain (2006) 1.00
Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol (2003) 0.99
Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J Neurosci Methods (2005) 0.99
Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J Immunol (2005) 0.98
Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol (2009) 0.97
Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Curr Drug Targets Immune Endocr Metabol Disord (2005) 0.96
The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. J Immunol (2006) 0.96
Treatment of neuromyelitis optica: current debate. Ther Adv Neurol Disord (2008) 0.95
Heterozygous null mutation of myelin P0 protein enhances susceptibility to autoimmune neuritis targeting P0 peptide. Eur J Immunol (2003) 0.94
Long-day suppressed expression of type 2 deiodinase gene in the mediobasal hypothalamus of the Saanen goat, a short-day breeder: implication for seasonal window of thyroid hormone action on reproductive neuroendocrine axis. Endocrinology (2005) 0.93
Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Arthritis Rheum (2007) 0.93
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. J Neuroimmunol (2007) 0.92
Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-kappaB as a biomarker for relapse of multiple sclerosis. Dis Markers (2008) 0.92
More sympathy for autoimmunity with neuropeptide Y? Trends Immunol (2004) 0.90
The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. Am J Pathol (2004) 0.90
Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis. J Immunol (2006) 0.90
[Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument]. Rinsho Shinkeigaku (2004) 0.89
A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease. J Neurol Sci (2006) 0.89
Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania. Eur J Immunol (2008) 0.89
Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica. PLoS One (2013) 0.89
Kisspeptin as a master player in the central control of reproduction in mammals: an overview of kisspeptin research in domestic animals. Anim Sci J (2013) 0.88
Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling. PLoS One (2013) 0.87
CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis. J Immunol (2012) 0.86
Electrophysiological and morphological evidence for synchronized GnRH pulse generator activity among Kisspeptin/neurokinin B/dynorphin A (KNDy) neurons in goats. J Reprod Dev (2012) 0.85
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C. Intern Med (2012) 0.85
Human astrocytes express 14-3-3 sigma in response to oxidative and DNA-damaging stresses. Neurosci Res (2006) 0.83
Minimum structure requirement of immunomodulatory glycolipids for predominant Th2 cytokine induction and the discovery of non-linear phytosphingosine analogs. Bioorg Med Chem Lett (2007) 0.83
A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation. Arthritis Res Ther (2012) 0.83
Retinoid signals and Th17-mediated pathology. Nihon Rinsho Meneki Gakkai Kaishi (2009) 0.83
Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis. J Neuroimmunol (2003) 0.82
Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions. Neuropathology (2008) 0.82
Development of a culture system to induce microglia-like cells from haematopoietic cells. Neuropathol Appl Neurobiol (2014) 0.82
Sex steroid-induced neuroplasticity and behavioral activation in birds. Eur J Neurosci (2010) 0.82
New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis. Muscle Nerve (2002) 0.81
Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neurol Sci (2009) 0.81
GRAIL (gene related to anergy in lymphocytes) regulates cytoskeletal reorganization through ubiquitination and degradation of Arp2/3 subunit 5 and coronin 1A. J Biol Chem (2011) 0.80
A population of kisspeptin/neurokinin B neurons in the arcuate nucleus may be the central target of the male effect phenomenon in goats. PLoS One (2013) 0.80
Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism. Am J Pathol (2009) 0.79
Localization of NK1.1(+) invariant Valpha19 TCR(+) cells in the liver with potential to promptly respond to TCR stimulation. Immunol Lett (2008) 0.79
Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis. BMC Neurol (2014) 0.79
Role of NK cells and invariant NKT cells in multiple sclerosis. Results Probl Cell Differ (2010) 0.79
Psychological stress increases human T cell apoptosis in vitro. Neuroimmunomodulation (2003) 0.79
Abnormalities of cerebral blood flow in multiple sclerosis: a pseudocontinuous arterial spin labeling MRI study. Magn Reson Imaging (2013) 0.79
Molecular mechanism of photoperiodic time measurement in the brain of Japanese quail. Chronobiol Int (2006) 0.79
Total synthesis of an immunosuppressive glycolipid, (2S,3S,4R)-1-O- (alpha-d-galactosyl)-2- tetracosanoylamino-1,3,4-nonanetriol. J Org Chem (2005) 0.78
Peripheral clock gene expression in CS mice with bimodal locomotor rhythms. Neurosci Res (2006) 0.78
Tissue culture methods to study neurological disorders: establishment of immortalized Schwann cells from murine disease models. Neuropathology (2003) 0.78
Aberrant transcriptional regulatory network in T cells of multiple sclerosis. Neurosci Lett (2007) 0.78
Involvement of transforming growth factor alpha in the photoperiodic regulation of reproduction in birds. Endocrinology (2007) 0.78
Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile. Bioorg Med Chem (2012) 0.78
Epiregulin is critical for the acinar cell regeneration of the submandibular gland in a mouse duct ligation model. J Oral Pathol Med (2013) 0.78
Red jungle fowl (Gallus gallus) as a model for studying the molecular mechanism of seasonal reproduction. Anim Sci J (2009) 0.78
Synthetic glycolipid ligands for human iNKT cells as potential therapeutic agents for immunotherapy. Curr Med Chem (2008) 0.77